골전이가 없는 자궁내막암 환자의 골밀도에 관한 후향적 연구
A Retrospective Study of Bone Mineral Density in Patients with Endometrial Cancer without Bone Metastases
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This retrospective study evaluated bone mineral density (BMD) in postmenopausal endometrial cancer patients without bone metastases. Materials and Methods: We retrospectively analyzed the BMD of spinal bone and the femur in 26 endometrial cancer patients and 32 control women. All of the patients and control women had reached their menopause. The control group was treated with benign uterine myoma whose age and body mass index are consistent with the case group. All BMD was measured by dual-energy X-ray absorptiometry. Results: Among the serum calcium concentrations and bone markers, alkaline phosphatase level was higher in endometrial cancer group than in controls. BMD of 4th lumbar vertebra was significantly lower in endometrial cancer patients (T-score: -0.63±0.77) than in controls (T-score: 0.88±1.83). Serum calcium concentration was higher in stage I patients (9.63±0.31 mg/dL) than that in stage II-III patients (9.26±0.31 mg/dL). BMD of 1st vertebra was lower in stage I patients (T-score: -1.80±0.97) than that in stage II-III patients (T-score: -0.60±0.95). Conclusions: We observed the increase of bone turnover along with the decrease of BMD in endometrial cancer which is estrogen dependent malignancy. Bone turnover increase and BMD decrease was even more distinct in early stage of endometrial cancer than later stages. A prospective randomized trial in large scale is warranted to elucidate the relation between the factors affecting bone density in endometrial cancer.
Abstract
Objectives: This retrospective study evaluated bone mineral density (BMD) in postmenopausal endometrial cancer patients without bone metastases. Materials and Methods: We retrospectively analyzed the BMD of spinal bone and the femur in 26 endometrial cancer patients and 32 control women. All of the patients and control women had reached their menopause. The control group was treated with benign uterine myoma whose age and body mass index are consistent with the case group. All BMD was measured by dual-energy X-ray absorptiometry. Results: Among the serum calcium concentrations and bone markers, alkaline phosphatase level was higher in endometrial cancer group than in controls. BMD of 4th lumbar vertebra was significantly lower in endometrial cancer patients (T-score: -0.63±0.77) than in controls (T-score: 0.88±1.83). Serum calcium concentration was higher in stage I patients (9.63±0.31 mg/dL) than that in stage II-III patients (9.26±0.31 mg/dL). BMD of 1st vertebra was lower in stage I patients (T-score: -1.80±0.97) than that in stage II-III patients (T-score: -0.60±0.95). Conclusions: We observed the increase of bone turnover along with the decrease of BMD in endometrial cancer which is estrogen dependent malignancy. Bone turnover increase and BMD decrease was even more distinct in early stage of endometrial cancer than later stages. A prospective randomized trial in large scale is warranted to elucidate the relation between the factors affecting bone density in endometrial cancer.
참고문헌 (17)
- Report of a WHO Study Group, "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis", World Health Organ Tech Rep Ser, 843, pp.1~129 (1994)
- "The Third Korea National Health & Nutrition Examination Survey (KNHANES Ⅴ-1), 2010" (2011)[URL]
- Moseley JM, "Parathyroid hormone-related protein purified from a human lung cancer cell line", Proc Natl Acad Sci U S A, 84, pp.5048~5052 (1987)
- Strewler GJ, "Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone", J Clin Invest, 80, pp.1803~1807 (1987)
- Burtis WJ, "Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy", J Biol Chem, 262, pp.7151~7156 (1987)
- Cho SH, "Reduced spinal bone mass in patients with uterine cervical cancer", Obstet Gynecol, 78, pp.689~692 (1991)
- "2010. Statistics of Canvcr Registration" (2010)[URL]
- Troyer H, "Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts", Am J Pathol, 108, pp.284~290 (1982)
- Stewart AF, "Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity", J Clin Endocrinol Metab, 55, pp.219~227 (1982)
- Lee SH, "Decreased bone mineral density of femur in patients with cervical cancer", J Obstet Gynaecol Res, 35, pp.335~338 (2009)
- "Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis", Am J Med, 94, pp.646~650 (1993)
- Gillette-Guyonnet S, "Body composition and osteoporosis in elderly women", Gerontology, 46, pp.189~193 (2000)
- Lee SH, "Bone Mineral Density in Patients with Endometrial Cancer", J Korean Society of Menopause, 15, pp.35~40 (2009)
- Stevenson JC, "Pathogenesis, prevention, and treatment of osteoporosis", Obstet Gynecol, 75, pp.36S~41S (1990)
- Nguyen TV, "Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures", J Clin Endocrinol Metabo, 80, pp.2709~2714 (1995)
- Cox ML, "Determinants of forearm bone density in premenopausal women: a study in one general practice", Br J Gen Pract, 41, pp.194~196 (1991)
- Marcus R, "Correlations of bone mineral density in the postmenopausal estrogen", progestin intervention trial, 1994, pp.9, 1467~1476